![Mitchell Finer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mitchell Finer
Director/Board Member at
PEPGEN INC.
Net worth: - $ as of 31/05/2026
Profile
Mitchell H.
Finer founded Cell Genesys, Inc. in 1989, where he worked as Vice President-Research from 1989 to 1999, Adverum Biotechnologies, Inc. in 2006, where he worked as Director from 2006 to 2019, Oncorus, Inc. in 2015, where he worked as Director in 2023, ElevateBio LLC in 2017, where he worked as Director, President-Research & Development from 2017 to 2024, and CODA Biotherapeutics, Inc. in 2014, where he worked as Director from 2014 to 2022.
Dr. Finer also founded Abgenix, Inc., where he worked as Principal.
Dr. Finer also currently works at Abata Therapeutics, Inc., as Director, Tabby Therapeutics Ltd., as Director, and PepGen Inc., as Independent Non-Executive Director from 2025.
Dr. Finer also formerly worked at Intracel Corp., as Chief Executive Officer from 2005 to 2007, Genteric, Inc., as President & Chief Executive Officer from 2003 to 2005, Intracel Resources LLC, as Chief Executive Officer, Intracel Holdings Corp., as Chief Executive Officer from 2005 to 2008, LifeEDIT Therapeutics, Inc., as Chief Executive Officer, MPM BioImpact LLC, as Managing Director, Candel Therapeutics, Inc., as Director, TCR² Therapeutics, Inc., as Independent Director from 2015 to 2020, Semma Therapeutics, Inc., as Director, Turmeric Acquisition Corp., as Independent Director, SaviCorp, as Vice President-Research & Development, ViaCyte, Inc., as Senior Vice President-Development from 2008 to 2010, Aventis Pharmaceuticals, Inc., as Vice President-Gencell Division from 1999 to 2002, Sanofi India Ltd., as Vice President-Research, Genetix Biotherapeutics, Inc., as Chief Scientific Officer from 2010 to 2015, and Elevatebio Base Camp, Inc., as President from 2019 to 2021.
Dr. Finer received his doctorate degree in 1986 from Harvard University and undergraduate degree in 1979 from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PEPGEN INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Mitchell Finer active positions
| Companies | Position | Start |
|---|---|---|
| PEPGEN INC. | Director/Board Member | 27/03/2025 |
Tabby Therapeutics Ltd.
 Tabby Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutic drugs | Director/Board Member | - |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Director/Board Member | - |
Former positions of Mitchell Finer
| Companies | Position | End |
|---|---|---|
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology Operates as biotechnology holding company, which develops gene therapy and manufactures & commercializes life-transforming medicines | Founder | 01/05/2024 |
| ONCORUS, INC. | Chief Executive Officer | 01/07/2018 |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Founder | 01/10/2022 |
Elevatebio Base Camp, Inc.
 Elevatebio Base Camp, Inc. Part of ElevateBio LLC, Elevatebio Base Camp, Inc. is a technology-driven cell and gene therapy company. The company is based in Waltham, MA. ElevateBio aims to accelerate access to cutting-edge technologies and expertise to change the future of medicine. The company offers turnkey scale and biotechnological capabilities to power cell and cell therapy processes, programs, and companies. ElevateBio provides end-to-end expert support capabilities for cell and gene therapies, with a team of seasoned drug developers who provide guidance and partners throughout every step of the development and manufacturing process. The company's mission is to be the dominant engine inside the world's greatest scientific advancements harnessing human cells and genes to treat diseases. The company aims to change how organizations operate, how products are created, and how diseases are treated. | President | 01/12/2021 |
| TCR2 THERAPEUTICS INC. | Director/Board Member | 04/05/2020 |
Training of Mitchell Finer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
27
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 27 |
|---|---|
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
Intracel Corp.
 Intracel Corp. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products for serious viral diseases and cancer | Health Technology |
SaviCorp
 SaviCorp Movies/EntertainmentConsumer Services Creates and commercializes blow-by gas and crankcase engine emission reduction technology | Consumer Services |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi India Ltd.
 Sanofi India Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical drugs | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genteric, Inc.
 Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Health Technology |
Intracel Resources LLC
 Intracel Resources LLC BiotechnologyHealth Technology Develops vaccines, immunotherapeutic products, and cardiovascular disease research solutions | Health Technology |
Intracel Holdings Corp.
 Intracel Holdings Corp. BiotechnologyHealth Technology Developes highest quality cardiovascular disease research products | Health Technology |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
Oncorus, Inc.
 Oncorus, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Health Technology |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology Operates as biotechnology holding company, which develops gene therapy and manufactures & commercializes life-transforming medicines | Health Technology |
Elevatebio Base Camp, Inc.
Elevatebio Base Camp, Inc. Part of ElevateBio LLC, Elevatebio Base Camp, Inc. is a technology-driven cell and gene therapy company. The company is based in Waltham, MA. ElevateBio aims to accelerate access to cutting-edge technologies and expertise to change the future of medicine. The company offers turnkey scale and biotechnological capabilities to power cell and cell therapy processes, programs, and companies. ElevateBio provides end-to-end expert support capabilities for cell and gene therapies, with a team of seasoned drug developers who provide guidance and partners throughout every step of the development and manufacturing process. The company's mission is to be the dominant engine inside the world's greatest scientific advancements harnessing human cells and genes to treat diseases. The company aims to change how organizations operate, how products are created, and how diseases are treated. | |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
PepGen Inc.
 PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Health Technology |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome editing and engineering services | Commercial Services |
Tabby Therapeutics Ltd.
Tabby Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutic drugs | Health Technology |
- Stock Market
- Insiders
- Mitchell Finer
Choose MarketScreener 
